Q4 2018 Holdings
Filed 2019-01-22 | 10 holdings | $202.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $103.1M | 3,608,874 | 51.0% |
| Veracyte, Inc.(VCYT) | Common Stock | 92337F107 | $45.5M | 3,616,221 | 22.5% |
| Audentes Therapeutics, Inc.(BOLDEUR) | Common Stock | 05070R104 | $25.7M | 1,204,615 | 12.7% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $8.8M | 2,215,384 | 4.4% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $8.5M | 1,084,696 | 4.2% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $4.0M | 4,492,975 | 2.0% |
| ImmuneDesign Corp. | Common Stock | 45252L103 | $2.9M | 2,208,210 | 1.4% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $1.8M | 101,855 | 0.9% |
| Achaogen, Inc. | Common Stock | 004449104 | $1.6M | 1,281,152 | 0.8% |
| OpGen, Inc. | Common Stock | 68373L109 | $132.8K | 102,167 | 0.1% |